anmelden
SLI
2.297,53
PKT
-6,73
PKT
-0,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.01.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 28.01.22 | Givaudan Add | Baader Bank | |
| 28.01.22 | Givaudan Underperform | Bernstein Research | |
| 27.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 27.01.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 27.01.22 | Swiss Re Sell | UBS AG | |
| 26.01.22 | UBS Buy | Jefferies & Company Inc. | |
| 26.01.22 | Roche Buy | Deutsche Bank AG | |
| 26.01.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.01.22 | Holcim Buy | UBS AG | |
| 26.01.22 | UBS Underweight | Barclays Capital | |
| 25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 25.01.22 | UBS Sector Perform | RBC Capital Markets | |
| 25.01.22 | UBS Neutral | UBS AG | |
| 24.01.22 | Richemont Outperform | Bernstein Research | |
| 24.01.22 | Zurich Insurance Buy | Kepler Cheuvreux | |
| 24.01.22 | ABB (Asea Brown Boveri) Buy | Kepler Cheuvreux | |
| 24.01.22 | UBS Underweight | Barclays Capital | |
| 24.01.22 | UBS Equal Weight | Barclays Capital | |
| 24.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 24.01.22 | Swiss Re Outperform | Credit Suisse Group | |
| 21.01.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 21.01.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.22 | Richemont Buy | Deutsche Bank AG | |
| 21.01.22 | Richemont Overweight | Barclays Capital | |
| 20.01.22 | Richemont Buy | Kepler Cheuvreux | |
| 20.01.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.22 | Swiss Re Overweight | Barclays Capital | |
| 20.01.22 | Richemont Neutral | Credit Suisse Group | |
| 20.01.22 | Richemont Buy | UBS AG | |
| 20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.01.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.22 | Richemont Buy | Kepler Cheuvreux | |
| 19.01.22 | UBS Buy | Kepler Cheuvreux | |
| 19.01.22 | Givaudan Underweight | Barclays Capital | |
| 19.01.22 | Richemont Buy | UBS AG | |
| 19.01.22 | Richemont Outperform | RBC Capital Markets |
